Technology | February 28, 2014

FDA Clears IMRIS Visius Surgical Theatre Upgrade

IMRIS Visius Surgical Theatre MRI Systems Angiography Hybrid OR

February 28, 2014 — The U.S. Food and Drug Administration (FDA) cleared IMRIS Inc.’s upgraded Visius Surgical Theatre, which integrates Siemens' high-field MR scanners.

The core imaging technology based on Siemens Aera 1.5T(tesla) and Skyra 3.0T technology helps IMRIS deliver better image quality with higher signal-to-noise ratio. It also provides faster 3-D image acquisition and improved ease-of-use and workflow during neurosurgical procedures using intraoperative MRI (iMRI).

The addition of these MR systems expands the 1.5T and 3.0T MRI choices hospitals have when considering the ceiling-mounted IMRIS solution for intraoperative imaging, which brings the MRI to the patient during the procedure.

The first installation of this new generation Visius Surgical Theatre will be a four-room hybrid operating room suite, known as the Center for Surgical Innovation (CSI) at Dartmouth-Hitchcock Medical Center in Lebanon, N.H. 

The Dartmouth-Hitchcock installation will also include a Visius intraoperative CT (iCT), which utilizes the technology of the 64-slice Siemens Somatom Definition AS scanner, making it an operating suite with both Visius iMRI and iCT modalities able to serve multiple operating rooms without moving the patient.

Inside a Visius Surgical Theatre equipped with either high-field iMRI or iCT, surgeons have on-demand access to real-time data and imaging during the procedure from the OR table.

For more information: www.imris.com 


Additional Content

News | Angiography

Oct. 21, 2025 — SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for ...

Home October 24, 2025
Home
News | Angiography

Sept. 30, 2025 — Cleerly has announced that coverage policies from UnitedHealthcare and Cigna for Cleerly LABS advanced ...

Home September 30, 2025
Home
News | Angiography

July 28, 2025 — AngioDynamics, Inc. has announced enrollment of the first patient in the Randomized Study of the Auryon ...

Home July 28, 2025
Home
News | Angiography

April 25, 2025 — The annual Society for Cardiovascular Angiography & Interventions (SCAI) meeting, SCAI 2025 Scientific ...

Home April 25, 2025
Home
News | Angiography

March 17, 2025 – Ostial Corp., a privately held medical technology company focused on addressing the clinical challenges ...

Home March 18, 2025
Home
Subscribe Now